CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis Biological Versus Chronological Aging: JACC Focus Seminar Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)

Review Article2020 Apr 24;126(9):1107-1111.

JOURNAL:Circ Res. Article Link

How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research

P Libby , KE Bornfeldt. Keywords: allergy and immunology; atherosclerosis; CAD; endothelium; thrombosis.

Full Text PDF